2 Aronowski J, & Hall CE: New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies. Neurol Res 27:268–279, 2005
PubMed Aronowski J, Hall CE: New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies. Neurol Res 27:268–279, 2005 )| false
4 Broderick JP, , Adams HP Jr, , Barsan W, , Feinberg W, , Feldmann E, & Grotta J, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 30:905–915, 1999
PubMed Broderick JP, Adams HP Jr, Barsan W, Feinberg W, Feldmann E, Grotta J, : Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 30:905–915, 1999 )| false
6 Cheng AL, , Hsu CH, , Lin JK, , Hsu MM, , Ho YF, & Shen TS, et al.: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21:4B 2895–2900, 2001
PubMed Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, : Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21:4B2895–2900, 2001 )| false
7 Choudhri TF, , Hoh BL, , Solomon RA, , Connolly ES Jr, & Pinsky DJ: Use of a spectrophotometric hemoglobin assay to objectively quantify intracerebral hemorrhage in mice. Stroke 28:2296–2302, 1997
PubMed Choudhri TF, Hoh BL, Solomon RA, Connolly ES Jr, Pinsky DJ: Use of a spectrophotometric hemoglobin assay to objectively quantify intracerebral hemorrhage in mice. Stroke 28:2296–2302, 1997 )| false
8 Christoforidis GA, , Slivka A, , Mohammad Y, , Karakasis C, , Avutu B, & Yang M: Size matters: hemorrhage volume as an objective measure to define significant intracranial hemorrhage associated with thrombolysis. Stroke 38:1799–1804, 2007
PubMed Christoforidis GA, Slivka A, Mohammad Y, Karakasis C, Avutu B, Yang M: Size matters: hemorrhage volume as an objective measure to define significant intracranial hemorrhage associated with thrombolysis. Stroke 38:1799–1804, 2007 )| false
10 Davis SM, , Broderick J, , Hennerici M, , Brun NC, , Diringer MN, & Mayer SA, et al.: Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 66:1175–1181, 2006
PubMed Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, : Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 66:1175–1181, 2006 )| false
12 Dhandapani KM, , Khan MM, , Wade FM, , Wakade C, , Mahesh VB, & Brann DW: Induction of transforming growth factorbeta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation. J Neurosci Res 85:1033–1045, 2007
PubMed Dhandapani KM, Khan MM, Wade FM, Wakade C, Mahesh VB, Brann DW: Induction of transforming growth factorbeta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation. J Neurosci Res 85:1033–1045, 2007 )| false
13 Dhandapani KM, , Mahesh VB, & Brann DW: Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem 102:522–538, 2007
PubMed Dhandapani KM, Mahesh VB, Brann DW: Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem 102:522–538, 2007 )| false
15 Dhillon N, , Aggarwal BB, , Newman RA, , Wolff RA, , Kunnumakkara AB, & Abbruzzese JL, et al.: Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14:4491–4499, 2008
PubMed Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, : Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14:4491–4499, 2008 )| false
19 Garodia P, , Ichikawa H, , Malani N, , Sethi G, & Aggarwal BB: From ancient medicine to modern medicine: ayurvedic concepts of health and their role in inflammation and cancer. J Soc Integr Oncol 5:25–37, 2007
PubMed Garodia P, Ichikawa H, Malani N, Sethi G, Aggarwal BB: From ancient medicine to modern medicine: ayurvedic concepts of health and their role in inflammation and cancer. J Soc Integr Oncol 5:25–37, 2007 )| false
22 Kim JS, , Yoon SS, , Kim YH, & Ryu JS: Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke 27:1553–1557, 1996
PubMed Kim JS, Yoon SS, Kim YH, Ryu JS: Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke 27:1553–1557, 1996 )| false
24 Laird MD, , Sukumari-Ramesh S, , Swift AE, , Meiler SE, , Vender JR, & Dhandapani KM: Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4?. J Neurochem 113:637–648, 2010
PubMed Laird MD, Sukumari-Ramesh S, Swift AE, Meiler SE, Vender JR, Dhandapani KM: Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4?. J Neurochem 113:637–648, 2010 )| false
26 Leira R, , Dávalos A, , Silva Y, , Gil-Peralta A, , Tejada J, & Garcia M, et al.: Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 63:461–467, 2004
PubMed Leira R, Dávalos A, Silva Y, Gil-Peralta A, Tejada J, Garcia M, : Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 63:461–467, 2004 )| false
28 Mayne M, , Ni W, , Yan HJ, , Xue M, , Johnston JB, & Del Bigio MR, et al.: Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-alpha expression is neuroprotective after intracerebral hemorrhage. Stroke 32:240–248, 2001
PubMed Mayne M, Ni W, Yan HJ, Xue M, Johnston JB, Del Bigio MR, : Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-alpha expression is neuroprotective after intracerebral hemorrhage. Stroke 32:240–248, 2001 )| false
32 Qin Z, , Karabiyikoglu M, , Hua Y, , Silbergleit R, , He Y, & Keep RF, et al.: Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia. Stroke 38:1362–1367, 2007
PubMed Qin Z, Karabiyikoglu M, Hua Y, Silbergleit R, He Y, Keep RF, : Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia. Stroke 38:1362–1367, 2007 )| false
34 Rajeevan MS, , Ranamukhaarachchi DG, , Vernon SD, & Unger ER: Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. Methods 25:443–451, 2001
PubMed Rajeevan MS, Ranamukhaarachchi DG, Vernon SD, Unger ER: Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. Methods 25:443–451, 2001 )| false
35 Rynkowski MA, , Kim GH, , Komotar RJ, , Otten ML, , Ducruet AF, & Zacharia BE, et al.: A mouse model of intracerebral hemorrhage using autologous blood infusion. Nat Protoc 3:122–128, 2008
PubMed Rynkowski MA, Kim GH, Komotar RJ, Otten ML, Ducruet AF, Zacharia BE, : A mouse model of intracerebral hemorrhage using autologous blood infusion. Nat Protoc 3:122–128, 2008 )| false
40 Thiyagarajan M, & Sharma SS: Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 74:969–985, 2004
PubMed Thiyagarajan M, Sharma SS: Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 74:969–985, 2004 )| false
43 Wasserman JK, , Zhu X, & Schlichter LC: Evolution of the inflammatory response in the brain following intracerebral hemorrhage and effects of delayed minocycline treatment. Brain Res 1180:140–154, 2007
PubMed Wasserman JK, Zhu X, Schlichter LC: Evolution of the inflammatory response in the brain following intracerebral hemorrhage and effects of delayed minocycline treatment. Brain Res 1180:140–154, 2007 )| false
45 Wright JL, & Merchant RE: Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat. J Neurooncol 20:17–25, 1994
PubMed Wright JL, Merchant RE: Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat. J Neurooncol 20:17–25, 1994 )| false